Skip to main content
Filing year 2023

THE CHOLANGIOCARCINOMA FOUNDATION

Salt Lake City, Utah·EIN 20-5776861·NTEE H99 · Medical Research·501(c)(3)
Total revenue
$6.9M
Total assets
$6M
Total expenses
$6.2M
Reported officers
14
Mission

THE ORGANIZATION'S MISSION IS TO FIND A CURE AND IMPROVE THE QUALITY OF LIFE FOR CHOLANGIOCARCINOMA PATIENTS.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 4 reported individuals · Filing year 2023

Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.

Ceo/founder
Officer (Unspecified)
$210k
$230k
Base
$186k
Bonus
$16k
Other
Benefits
$4k
Cdo
Median to 75th percentile
$162k
$177k
Base
$150k
Bonus
Other
Benefits
$6k
COO
25th percentile to median
$161k
$176k
Base
$142k
Bonus
$11k
Other
Benefits
$2k
CPO
Highest Compensated Employee
Below 10th percentile
$107k
$117k

Teal figures restate each filed amount in 2026 dollars.

Estimated with BLS CPI-U for the West region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 10 unpaid individuals.

Browse compensation in Medical Research

Pay in context

Top pay as a share of expenses

In 2023, the highest total compensation at THE CHOLANGIOCARCINOMA FOUNDATION equaled 3% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2023)
3%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

1
THE CHOLANGIOCARCINOMA FOUNDATION2023
$210k
2
Young Living Foundation2024
$16k
Compare compensation across all Medical Research organizations
FAQ

Common questions about THE CHOLANGIOCARCINOMA FOUNDATION

What does the Chief Development Officer of THE CHOLANGIOCARCINOMA FOUNDATION earn?

In 2023, the Chief Development Officer of THE CHOLANGIOCARCINOMA FOUNDATION received $161,559 in total compensation. This pay is above the median (the midpoint) for Chief Development Officer roles among Medical Research organizations nationwide, within the top half of comparable filings. Based on IRS Form 990 data.

How does Chief Development Officer pay at THE CHOLANGIOCARCINOMA FOUNDATION compare with similar nonprofits?

Compared with the same role at Medical Research organizations nationwide, the 2023 pay of the Chief Development Officer at THE CHOLANGIOCARCINOMA FOUNDATION falls between the median and the 75th percentile. In 2023, the highest total compensation at THE CHOLANGIOCARCINOMA FOUNDATION equaled 3% of the organization's total expenses. The median for medical research organizations is 10%.

What are THE CHOLANGIOCARCINOMA FOUNDATION's revenue and expenses?

In 2023, THE CHOLANGIOCARCINOMA FOUNDATION reported $6.9M in total revenue and $6.2M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.